Post-approval studies (Phase 4)Study completedNCT02436408
What this trial is testing
VISmodegib for ORbital and Periocular Basal Cell Carcinoma
Who this might be right for
Carcinoma, Basal Cell
University of Michigan Rogel Cancer Center 35
Showing 17 of 0 results